title: Surgical prophylaxis with gram-negative activity for reduction of surgical site infections after microvascular reconstruction for head and neck cancer.
abstract: The purpose of this study was to determine the incidence of and risk factors for surgical site infections in microvascular reconstruction for patients with head and neck cancer.
  
  
  
  One hundred seventeen patients with head and neck cancer undergoing microvascular reconstruction received postoperative surgical infection prophylaxis and were followed for 30 days. Surgical infection prophylaxis was categorized by empiric spectrum of activity. Risk factors for surgical site infection development and cumulative incidence of surgical site infections were characterized.
  
  
  
  Thirty-seven patients developed surgical site infection (cumulative surgical site infection incidence of 31.6%). Risk factors identified in logistic regression include alcohol use (odds ratio [OR] = 2.704; 95% confidence interval [CI] = 1.029-7.106), increased surgical duration (OR = 1.403; 95% CI = 1.185-1.661), American Society of Anesthesiologists (ASA) class IV (OR = 3.075; 95% CI = 1.000-9.459), and lack of postoperative gram-negative coverage (OR = 15.139; 95% CI = 3.083-74.347).
  
  
  
  Alcohol use, longer surgical duration, and lack of gram-negative postoperative prophylactic coverage are modifiable risk factors for surgical site infection development. © 2016 Wiley Periodicals, Inc. Head Neck 38: First-1454, 2016.
authors.affiliation: Department of Pharmacy Practice, University of Mississippi School of Pharmacy, Jackson, USA.|Pharmacy Administration, Henry Ford Hospital, Detroit, Michigan.|Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan.
authors.forename: Jamie L
authors.initials: JL
authors.lastname: Wagner
authors.affiliation: Pharmacy Administration, Henry Ford Hospital, Detroit, Michigan.
authors.forename: Rachel M
authors.initials: RM
authors.lastname: Kenney
authors.affiliation: Department of Infectious Diseases, Georgia Regents University, Augusta, Georgia.
authors.forename: Jose A
authors.initials: JA
authors.lastname: Vazquez
authors.affiliation: Pharmacy Administration, Henry Ford Hospital, Detroit, Michigan.
authors.forename: Tamer A
authors.initials: TA
authors.lastname: Ghanem
authors.affiliation: Pharmacy Administration, Henry Ford Hospital, Detroit, Michigan. sldavis@wayne.edu.|Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan. sldavis@wayne.edu.
authors.forename: Susan L
authors.initials: SL
authors.lastname: Davis
mesh_terms: D000328:Adult; D000368:Aged; D019072:Antibiotic Prophylaxis; D001419:Bacteria / Q000302:isolation & purification; D002175:Candida / Q000302:isolation & purification; D005260:Female; D058752:Free Tissue Flaps; D006258:Head and Neck Neoplasms / Q000601:surgery*; D006801:Humans; D015994:Incidence; D008297:Male; D055806:Microvessels; D008875:Middle Aged; D019651:Plastic Surgery Procedures; D013530:Surgical Wound Infection / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*
keywords: antibiotics; head and neck cancer; microvascular reconstruction; surgical prophylaxis; surgical site infection